Radiation Oncology/Toxicity/Small bowel
< Radiation Oncology < Toxicity
|
Small Bowel
- Also please see Toxicity/Pelvis
Acute GI toxicity
Roeske JC, Mundt AJ et al. Radiother Oncol (2003)
- Keep V45 <= 250 cc
- North Central Cancer Treatment Group, 2007 PMID 17401014 -- "Patient assessment of bowel function during and after pelvic radiotherapy: results of a prospective phase III North Central Cancer Treatment Group clinical trial." (Haddock MG, J Clin Oncol. 2007 Apr 1;25(10):1255-9.)
- Prospective. Data gathered as part of randomized trial evaluating sucralfate.
- Bowel movements: increased up to week 4, then slowly decreased. At baseline: median 1 BM. At 1 year: median 2 BMs
- Normalized symptoms: at 1 year: frequency, nocturnal BM, cramping, bleeding
- Persistent symptoms at 1 year: urgency, clustering, incontinence
This article is issued from Wikibooks. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.